CAS Medical Systems, Inc. to Present At the FBR Capital Markets Growth Conference

CAS Medical Systems, Inc. (Nasdaq:CASM), a medical device company focused on
innovative, non-invasive monitoring that is vital to patient care, today
announced that Andrew E. Kersey, President and Chief Executive Officer of
CASMED, will present an overview of the Company at the Friedman, Billings,
Ramsey & Co., Inc. Spring Investor Conference on May 28, 2008 at the Grand Hyatt
in New York, NY.

The presentation is scheduled to begin at 3:50 p.m. ET on Wednesday, May 28 and
will also be webcast live over the internet. The webcast may be accessed via the
Company's website at www.casmed.com, and will be accessible until August 28,
2008.

About CASMED(r) - Monitoring What's Vital

CAS Medical Systems, Inc. manufactures medical devices for non-invasive patient
monitoring. The Company's newest innovative product is the FORE-SIGHT(r)
Absolute Cerebral Oximeter -- the only cerebral oximeter with FDA clearance for
non-invasive, continuous measurement of absolute cerebral tissue oxygen
saturation for neonates, infants, children and adults. This information helps
avert brain damage or death during surgery and in critical care situations by
allowing clinicians to identify patients with dangerously low levels of cerebral
oxygen and intervene to reverse the condition. CASMED's initial market focus has
been the adult cardiovascular OR, where nearly 700,000 high risk surgeries are
performed each year in the U.S. In addition, a specialized sensor for
neonatal/infant use will be commercially available in the third quarter of 2008
to address the nearly 40,000 babies born every year with congenital heart
defects.

The Company's product lines include the high-acuity monitoring capabilities of
the FORE-SIGHT Absolute Cerebral Oximeter; the low-acuity monitoring of its full
line of vital signs monitoring products, proprietary non-invasive blood pressure
measurement technology, and supplies and service including blood pressure cuffs
and products for neonatal intensive care. CASMED products are designed to meet
the needs of a full spectrum of patient populations worldwide, ranging from
adults to pediatrics and neonates.

For further information regarding CAS Medical Systems, Inc., visit the Company's
website at www.casmed.com.

The CAS Medical Systems, Inc. logo is available at
http://www.primenewswire.com/newsroom/prs/?pkgid=4675

Statements included in this press release, which are not historical in nature,
are forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Statements relating to the
future financial performance of the Company are subject to many factors
including, but not limited to, the customer acceptance of the products in the
market, the introduction of competitive products and product development,
commercialization and technological difficulties, the impact of actions and
events involving key customers and vendors, and other risks detailed in the
Company's Form 10-K for the year ended December 31, 2007 and other subsequent
Securities and Exchange Commission filings.

Such statements are based upon the current beliefs and expectations of the
Company's management and are subject to significant risks and uncertainties.
Actual results may differ from those set forth in the forward-looking
statements. When used in this press release the terms "anticipate", "believe",
"estimate", "expect", "may", "objective", "plan", "possible", "potential",
"project", "will" and similar expressions identify forward-looking statements.
The forward-looking statements contained in this press release are made as of
the date hereof, and we do not undertake any obligation to update any
forward-looking statements, whether as a result of future events, new
information or otherwise.

-0-
CONTACT: CAS Medical Systems, Inc.
Susan Carron, Director of Corporate Communications
203-488-6056
ir@casmed.com